Following yesterday’s Personal Consumption Expenditures (PCE) and Wednesday’s Fed meeting and press conference with Fed Chair Kevin Warsh, we quiet down ahead of the final trading session for the week. Despite some mid-week turbulence, we’re trading fairly even with where we were as of mid-day Monday. The Dow is +179 points at this hour, the S&P 500 +12 and the Nasdaq +241 points.
Q2 Employment Costs are out this morning, but unlikely to move the needle in terms of trading sentiment. The headline +0.9% matches the previous quarter and +10 basis points (bps) from expectations. Wages and salaries for civilian workers came in at +3.2%, benefits +3.8%. For state and local government workers, this adjusts to +3.6%.
Q2 Earnings at a Glance: ABBV, XOM & More
AbbVie (ABBV) shares are trading down at this hour, following a beat by a penny on the bottom line to $3.65 per share on revenues of $16.99 billion, +1.07%. The Big Pharma staple has not missed on earnings since 2018. But full-year earnings guidance was pulled lower than current projections, and shares are down -4% presently.
A pair of International Integrated Oil & Gas “supermajors” also reported earnings this morning. ExxonMobil (XOM) posted a negative earnings surprise of -4.35% on lower quarterly oil production, for its second miss in the past four quarters. Chevron (CVX) beat estimates by +4.48%. Both companies blasted past revenues estimates by +21%, though only Chevron is trading higher.
Colgate-Palmolive (CL) outpaced earnings estimates, $0.99 per share versus $0.95, even though higher tariff costs dampened the household products major’s outlook. Revenues were fairly in-line with estimates at $5.36 billion, above the $5.11 billion reported a year ago. Shares are down -1.8% at this hour.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.